oxazolidin-2-one has been researched along with Bright Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hariu, M; Imai, H; Kabutoya, Y; Kamioka, Y; Seki, M; Shoji, M; Takano, K; Watanabe, Y | 1 |
1 other study(ies) available for oxazolidin-2-one and Bright Disease
| Article | Year |
|---|---|
Mycobacterium abscessus Associated Peritonitis with CAPD Successfully Treated Using a Linezolid and Tedizolid Containing Regimen Suggested Immunomodulatory Effects.
Topics: Adult; Anti-Bacterial Agents; Chronic Disease; Female; Glomerulonephritis; Humans; Immunocompromised Host; Linezolid; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Tetrazoles | 2020 |